Steve Davison obituary Other lives: Trade union executive and tutor who was chair of the executive council of Amicus The Guardian - UK · Jul 21
A $4.8 Billion Reason to Buy BioMarin Stock Today BioMarin stock soars as the biotech firm announces a $4.8 billion acquisition of Amicus Therapeutics. The transaction could push BMRN shares even higher in 2026. Barchart · Dec 22, 2025
Draft Amicus Brief in Chiles v. Salazar, the Professional Speech / Minor Conversion Therapy Case I've written an amicus brief on my own behalf in this case (here's the PDF version). I'll be filing it… The post Draft Amicus Brief in Chiles v. Salazar, the Professional Speech / Minor Conversion Therapy Case appeared first on Reason.com. Reason · Jun 10, 2025
Preserving the Issue of Whether Morrison v. Olson Should Be Overruled The Special Counsel is squarely on notice that the question of whether Morrison’s holding should be preserved or overruled is at issue. Reason · Jul 17, 2024
Can an Amicus Ask the Supreme Court to Overrule a Case Where the Parties Don't? The ACLU successfully asked the Court to reverse Wolf v. Colorado in Mapp v. Ohio. Reason · Jun 22, 2024
Amicus Brief Filed in Trump v. Griswold On Behalf of Professor Seth Barrett Tillman "By contrast, a holding that the President is not an 'Officer of the United States' would authoritatively resolve the Section 3 case against the Petitioner. In that event, it will be the people, and not judges, or state officials, or Congress, who will decide." Reason · Jan 9, 2024
Re-vamped: British horror film-makers Hammer and Amicus are back from the dead The British studios, which filled screens with bloody fangs, gothic monsters and heaving bosoms, have been resurrected for the 21st century The Guardian - UK · Oct 29, 2023
Short sharp shocks: the glorious return of the Amicus portmanteau horror film The studio that mastered the art of the gleefully ghoulish cinematic short-story collection in the 60s and 70s is set to return. It may just raise a terrific genre from the dead The Guardian - UK · Aug 16, 2023
SCOTUS Denies Leave To File Amicus Brief By Two Law Professors Who Failed To Provide 10 Days Of Notice The Court is enforcing Rule 37.2 strictly. Reason · May 22, 2023
Tributes to Hillsborough barrister who fought 'decades of lies' One lawyer said his death marked a "great loss to the law" Liverpool Echo · Dec 22, 2022
FDA Extends Review Of Amicus Therapeutics' AT-GAA For The Treatment Of Pompe Disease By Three Months The U.S. Benzinga · May 10, 2022
Gene Therapy Player Amicus Therapeutics Terminates SPAC Merger, Shares Fall Amicus Therapeutics Inc (NASDAQ: FOLD) has terminated its plans to spin off its gene therapy assets, citing 'existing market conditions.' Benzinga · Feb 24, 2022
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company Here's a roundup of top developments in the biotech space over the last 24 hours: Benzinga · Feb 24, 2022